NexgenRx, Inc. announced the retirement of John Hawkrigg from his position as a director of the corporation. Mr. Hawkrigg has served as a director of the company for the past nine years.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.29 CAD | +1.75% | +1.75% | +31.82% |
05-17 | NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-16 | Charles Burns Tenders Resignation as Director of NexgenRx Inc | CI |
1st Jan change | Capi. | |
---|---|---|
+31.82% | 14.95M | |
-5.31% | 114B | |
+8.89% | 102B | |
+7.51% | 64.37B | |
+15.87% | 45.1B | |
+12.32% | 42.37B | |
+20.86% | 35.9B | |
+7.30% | 25.8B | |
-3.49% | 22.52B | |
+0.76% | 18.58B |
- Stock Market
- Equities
- NXG Stock
- News NexgenRx Inc.
- NexgenRx, Inc. Announces Retirement of John Hawkrigg as Director